AMIT (The Alfred Mann Institute at the Technion)

An accelerator based in Haifa, Israel, focused on commercializing innovative biomedical technologies developed at the Technion.

Incubator Haifa, Israel Est. 2006
Last updated 2026-11-10
Portfolio
1
in our dataset
Rounds participated
2
Rounds led
1
Rounds' value
$8.5M
total disclosed, rounds participated
Stages
—

About

The Alfred Mann Institute at the Technion (AMIT) is a university-based institute in Haifa, Israel, established to accelerate the development and commercialization of biomedical innovations with the potential to impact human health. It acts as an accelerator, supporting technologies conceived by Technion students, faculty, and alumni, bridging the gap between academic research and commercial success.

Portfolio · 1

Q&A

What is AMIT's primary focus as an investor?
AMIT (The Alfred Mann Institute at the Technion) is an accelerator based in Haifa, Israel, focused on commercializing innovative biomedical technologies developed at the Technion.
What is AMIT's investment thesis?
AMIT's thesis is to enable the commercialization of innovative biomedical technologies that improve human health, specifically those developed at the Technion – Israel Institute of Technology.
What is the total AUM for AMIT?
AMIT has a total AUM of $100,000,000.
Which fund does AMIT manage?
AMIT manages the 'Alfred Mann Institute at the Technion Endowment' fund, established in 2006 with a size of $100,000,000.
What sectors does AMIT prefer to invest in?
AMIT primarily invests in the Health Tech & Life Sciences sectors.
What is AMIT's preferred geographic focus for investments?
AMIT's preferred geography for investments is Israel.
Who are some key individuals at AMIT?
Alfred Mann is the Founder & Chairman of the Board of Directors, and Zvi Hai Barnea (Burbea) is an MD at AMIT.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Legal nameAmit - Alfred Mann Institute AT the Technion Ltd.
Founded2006